While supporters of Turkey’s localization policy for pharmaceuticals implemented in 2016 applaud the changes it has brought, its opponents are…

Shirley Xu, president of Baxter Greater China, reflects on her extraordinary 26-year (and counting) career with Baxter China, including her…

In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few…

Long renowned for dancing to a different tune, Italy’s eccentric, but more often than not, enlightened and high performance pharma, healthcare and…

The President and MD of Abiogen Pharma discusses his family company's recent milestones, the reasons for persisting with local manufacturing, and the…

Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market…

The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing,…

The chairman and CEO of Santa Farma discusses how the Turkish pharmaceutical landscape has evolved in response to the government’s healthcare…

The managing director at Adcock Ingram Critical Care reveals the company's unique business model. As a long-established division within Adcock…

One of the directors of Romania's number one producer of suppositories and the only in-country manufacturer of contraceptive ovules speaks out about…

The CEO of Centurion shares his ambitious vision for the company's expansion into plasma products, biotech, orphan drugs, and generic injectables…